Shiga-like toxin subunit B (SLTB)-enhanced delivery of chlorin e6 (Ce6) improves cell killing

Photochemistry and Photobiology

Volumn 82, Issue 2, 2006, Pages 527-537

  Tarragó Trani, Maria Teresa ^a   Jiang, Shu ^b   Harich, Kim C ^a   Storrie, Brian ^b  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIN E6; PORPHYRIN; RADIOSENSITIZING AGENT; SHIGA TOXIN;

ANIMAL; ARTICLE; CELL DEATH; CELL LINE; CELL MEMBRANE; CERCOPITHECUS; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; DRUG INTERACTION; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; METABOLISM; MITOCHONDRION; PHOTOCHEMISTRY; VERO CELL;

ANIMALS; CELL DEATH; CELL LINE; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; DRUG INTERACTIONS; ENDOPLASMIC RETICULUM; GOLGI APPARATUS; MITOCHONDRIA; PHOTOCHEMISTRY; PORPHYRINS; RADIATION-SENSITIZING AGENTS; SHIGA TOXINS; VERO CELLS;

EID: 33646228868     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/2005-06-20-RA-583     Document Type: Article

References (54)

1. Blay, J. Y., A. L. Cesne, L. Alberti and I. R. Ray-Coquart (2005) Targeted cancer therapies. Bull. Cancer 92, E13-E18.
2. Ritcher, M. and H. Zhang (2005) Receptor-targeted cancer therapy. DNA Cell Biol. 24, 271-282.
3. Johannes, L. and D. Decaudin (2005) Protein toxins: intracellular trafficking for targeted therapy. Gene Ther. (advance online publication, DOI: 10.1038/sj.gt.3302557).
4. Sandvig, K. and B. van Deurs (2005) Delivery into cells: lessons learned from plant and bacterial toxins. Gene Ther. 12, 865-872.
5. Ross, J. S., K. Gray, G. S. Gray, P. J. Worland and M. Rolfe (2003) Anticancer antibodies. Am. J. Clin. Pathol. 119, 472-485.
6. Sharman W. M., J. E. van Lier and C. M. Allen (2004) Targeted photodynamic therapy via receptor mediated delivery systems. Adv. Drug. Deliv. Rev. 56, 53-76.
7. Sandvig K. and B. van Deurs (2002) Membrane traffic exploited by protein toxins. Annu. Rev. Cell Devel. Biol. 18, 1-24.
8. Gariepy, J. (2001) The use of Shiga-like toxin 1 in cancer therapy. Crit. Rev. Oncol./Hematol. 39, 99-106.
9. Sandvig, K. (2001) Shiga toxins. Toxicon 39, 1629-1635.
10. Pina, D. G. and L. Johannes (2005) Cholera and Shiga toxin B-subunits: thermodynamic and structural considerations for function and biomedical applications. Toxicon 45, 389-393.
11. 125I]verotoxin. Biochim. Biophys. Acta 1501, 116-124.
12. Hakomori, S. I. (2001) Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines. Adv. Exp. Med. Biol. 491, 369-402.
13. Tong, L., G. Baskaran, M. B. Jones, J. K. Rhee and K. J. Yarema (2003) Glycosylation changes as markers for the diagnosis and treatment of human disease. Biotechnol. Genet. Eng. Rev. 20, 199-244.
14. Arab, S., E. Russel, W. B. Chapman, B. Rosen and C. A. Lingwood (1997) Expression of the verotoxin receptor glycolipid, globotriaosylceramide, in ovarian hyperplasias. Oncol. Res. 9, 553-563, 1997.
15. La Casse, E. C., M. R. Bray, B. Patterson, W. M. Lim, S. Perampalam, L. Radvanyi, A. Keating, A. K. Stewart, R. Buckstein, J. S. Sandhu, N. Miller, D. Banerjee, D. Singh, A. R. Belch, L. M. Pilarski and J. Gariepy (1999) Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: Implications for ex vivo tumor purging and autologous stem cell transplantation. Blood, 94, 2901-2910.
16. Farkas-Hemsley, H., R. Hill, B. Rosen, S. Arab and C. A. Lingwood (1995) The bacterial colicin active against tumor cell in vitro and in vivo is verotoxin 1. Proc. Natl. Acad. Sci. USA 92, 6996-7000.
17. Mallard F., C. Antony, D. Tenza, J. Salamero, B. Goud and L. Johannes (1998) Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of shiga toxin B-fragment transport. J Cell Biol. 143, 973-90.
18. Girod A., B. Storrie, J. C. Simpson, L. Johannes, B. Goud, L. M. Roberts, J. M. Lord, T. Nilsson and R. Pepperkok (1999) Evidence for a COP-I-independent transport route from the Golgi complex to the endoplasmic reticulum. Nat. Cell Biol. 1, 423-430.
19. Maag, R. S., M. Mancini, A. Rosen and C. E. Machamer (2005) Caspase-resistant golgin 160 disrupts apoptosis induced by secretory pathway stress and ligation of death receptors. Mol. Biol. Cell 16, 3019-3027.
20. Soukos, N. S., M. R. Hamblin, S. Keel, R. L. Fabian, T. F. Deutsch and T. Hasan (2001) Epidermal growth factor receptor-targeted immnunophotodiagnosis and photoimmunotherapy of oral precancer in vivo. Cancer Res. 61, 4490-4496.
21. Gijsens, A., L. Missiaen, W. Merlevede and P. de Witte (2000) Epidermal growth factor-mediated targeting of chlorin e6 selectively potentiates its photodynamic activity. Cancer Res. 60, 2197-2202.
22. Akhlynina, T. V., D. A. Jans, A. A. Rosenkranz, N. V. Statsyuk, I. Y. Balashova, G. Toth, I. Pavo, A. B. Rubin and A. S. Sobolev (1997) Nuclear targeting of chlorin e6 enhances its photosensitizing activity. J. Biol. Chem. 272, 20328-20331.
23. Bisland, S. K., D. Singh and J. Gariepy (1999) Potentiation of chlorin e6 photodynamic activity in vitro with peptide-based intracellular vehicles. Bioconjug. Chem. 10, 982-992.
24. Oseroff, A. R., D. Ohuoha, T. Hasan, J. C. Bommer and M. L. Yarmush (1986) Antibody-targeted photolysis: selective photodestruction of human T-cell leukemia cells using monoclonal antibody-chlorin e6 conjugates. Proc. Natl. Acad. Sci. USA 83, 8744-8748.
25. Schmidt-Erfurth, U., H. Diddens, R. Birngruber and T. Hasan (1997) Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates. Br. J. Cancer 75, 54-61.
26. Hamblin, M. R., J. L. Miller and B. Ortel (2000) Scavenger-receptor targeted photodynamic therapy. Photochem. Photobiol. 72, 533-540.
27. Webber, J., B. Leeson, D. Fromm and D. Kessel (2005) Effects of photodynamic therapy using fractionated dosing of mono-L-aspartyl chlorin e6 in murine tumors. J. Photochem. Photobiol. B 78, 135-140.
28. Sharman, W. M., C. M. Allen and J. E. van Lier (1999) Photodynamic therapeutics: basic principles and clinical applications. Drug Discov. Today 4, 507-517.
29. Komath, S. S., K. Bhanu, B. G. Maiya and M. J. Swamy (2000) Binding of porphyrins by the tumor-specific lectin, Jacalin [jack fruit (Artocarpus integrifolia) agglutinin]. Biosci. Rep. 20, 265-276.
30. Gantchev, T. G., R. Oullet and J. E. van Lier (1999) Binding interactions and conformational changes induced by sulfonated aluminium phthalocyanines in human serum. Arch. Biochem. Biophys. 366, 21-30.
31. Aveline, B. M., T. Hasan and R. W. Redmond (1995) The effects of aggregation, protein binding and cellular incorporation on the photophysical properties of benzoporphyrin derivative monoacid ring A (BPDMA). J. Photochem. Photobiol. B Biol. 30, 161-169.
32. Savellano, M. D. and T. Hasan (2003) Targeting cells that overexpress the epidermal growth factor receptor with polyethylene glycolated BPD verteporfin photosensitizer immunoconjugates. Photochem. Photobiol. 77, 431-439.
33. Savellano, M. D. and T. Hasan (2005) Photochemical targeting of epidermal growth factor receptor: a mechanistic study. Clin. Cancer Res. 11, 1658-1668.
34. Sutton, J. M., O. J. Clarke, N. Fernandez and R. W. Boyle (2002) Porphyrin, chlorin, and bacteriochlorin isothiocyanates: useful reagents for the synthesis of photoactive bioconjugates. Bioconjug. Chem. 13, 249-263.
35. Tarragó-Trani, M. T. and B. Storrie (2004) A method for the purification of Shiga-like toxin 1 subunit B using a commercially available galabiose-agarose resin. Protein Expr. Purif. 38, 170-176.
36. Staros, J. V, R. W. Wright, and D. M. Swingle (1986) Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. Anal. Biochem. 156, 220-222.
37. Grabarek, Z. and J. Gergely (1990) Zero-length crosslinking procedure with the use of active esters. Anal. Biochem. 185, 131-135.
38. Southwick, P. L., L. A. Ernst, E. W. Tauriello, S. R. Parker, R. B. Mujumdar, S. R. Mujumdar, H. A. Clever, and A. S. Waggoner (1990) Cyanine dye labeling reagents-carboxymethylindocyanine succynimidyl esters. Cytometry 11, 418-430.
39. Brasseur, N., R. Langlois, C. La Madeleine, R. Oullet and J. E. van Lier (1999) Receptor-mediated targeting of phthalocyanines to macrophages via covalent coupling to native or maleylated bovine serum albumin. Photochem. Photobiol. 69, 345-352.
40. Hudson, R., M. Carcenac, K. Smith, L. Madden, O. J. Clarke, A. Pelegrin, J. Greenman and R. W. Boyle (2005) The development and characterization of porphyrin isothiocyanate-monoclonal antibody conjugates for photoimmunotherapy. Br. J. Cancer 92, 1442-1449.
41. 3. Biochemistry, 37, 1777-1788.
42. Fraser, M. E., M. M. Chernaia, Y. V. Kozlov and M. N. James (1994) Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 A resolution. Nat. Struct. Biol. 1, 59-64.
43. Pina, D. G., J. Gomez, E. Villar, L. Johannes and V. L. Shnyrov (2003) Thermodynamic analysis of the structural stability of the Shiga toxin B-subunit. Biochemistry 42, 9498-9506.
44. Cunderlikova, B., L. Gangeskar and J. Moan (1999) Acid-base properties of chlorin e6: relation to cellular uptake. J. Photochem. Photobiol. B Biol. 53, 81-90.
45. Merlin, J. L., H. Gautier, M. Barbieri-Heyob, M. H. Teiten and F. Guillemin (2003) The multidrug resistance modulator SDZ-PSC 833 potentiates the photodynamic activity of chlorin e6 independently of P-glycoprotein in multidrug resistant human breast adenocarcinoma cells. Int. J. Oncol. 22, 733-739.
46. Kelbauskas, L. and W. Dietel (2002) Internalization of aggregated photosensitizers by tumor cells: subcellular time-resolved fluorescence spectroscopy on derivatives of pyrophophorbide-a ethers and chlorin e6 under femtosecond one- and two-photon excitation. Photochem. Photobiol. 76, 686-694.
47. Storrie, B., M. T. Tarragó-Trani and S. English (2003) B/B-like fragment targeting for the purposes of photodynamic therapy and medical imaging. United States Patent 6,631,283.
48. Johannes, L., D. Tenza, C. Antony and B. Goud (1997) Retrograde transport of KDEL-bearing B fragment of Shiga toxin. J. Biol. Chem. 272, 19554-19561.
49. 3/CD77, a glycolipid antigen. Cancer Res. 53, 5314-5319.
50. L spare group I Burkitt lymphoma cells from CD77-directed killing via Verotoxin-1 B chain but fail to protect against the holotoxin. Cell Death Differ. 7, 785-794.
51. Marcato, P., G. Mulvey and G. D. Armstrong (2002) Cloned Shiga toxin 2 B subunit induces apoptosis in Ramos Burkitt's lymphoma B cells. Infect. Immun. 70, 1279-1286.
52. Williams, J. M., N. Lea, J. M. Lord, L. M. Roberts, D. V. Milford and C. M. Taylor (1997) Comparison of ribosome-inactivating proteins in the induction of apoptosis. Toxicol. Lett. 91, 121-127.
53. Hoey, D. E., L. Sharp, C. Currie, C. A. Lingwood, D. L. Gally and D. G. Smith (2003) Verotoxin 1 binding to intestinal crypt epithelial results in localization to lysosomes and abrogation of toxicity. Cell Microbiol. 5, 85-97.
54. Falguieres, T., F. Mallard, C. Baron, D. Hanau, C. A. Lingwood, B. Goud, J. Salamero and L. Johannes (2001) Targeting of Shiga toxin-subunit B to retrograde transport route in association with detergent-resistant membranes. Mol. Biol. Cell. 12, 2453-2468.